Comparison of deep learning‐based recurrence‐free survival with random survival forest and Cox proportional hazard models in Stage‐I NSCLC patients

Abstract Background The curative treatment for Stage I non‐small cell lung cancer (NSCLC) is surgical resection. Even for Stage I patients, the probability of recurrence after curative treatment is around 20%. Methods In this retrospective study, we included 268 operated Stage I NSCLC patients betwe...

Full description

Bibliographic Details
Main Authors: İrem Kar, Gökhan Kocaman, Farrukh İbrahimov, Serkan Enön, Erdal Coşgun, Atilla Halil Elhan
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.6479
Description
Summary:Abstract Background The curative treatment for Stage I non‐small cell lung cancer (NSCLC) is surgical resection. Even for Stage I patients, the probability of recurrence after curative treatment is around 20%. Methods In this retrospective study, we included 268 operated Stage I NSCLC patients between January 2008 and June 2018 to analyze the prognostic factors (pathological stage, histological type, number of sampled mediastinal lymph node stations, type of resection, SUVmax of the lesion) that may affect relapse with three different methods, Cox proportional hazard (CoxPH), random survival forest (RSF), DeepSurv, and to compare the performance of these methods with Harrell's C‐index. The dataset was randomly split into two sets, training and test sets. Results In the training set, DeepSurv showed the best performance among the three models, the C‐index of the training set was 0.832, followed by RSF (0.675) and CoxPH (0.672). In the test set, RSF showed the best performance among the three models, followed by DeepSurv with 0.677 and CoxPH methods with 0.625. Conclusion In conclusion, machine‐learning techniques can be useful in predicting recurrence for lung cancer and guide clinicians both in choosing the adjuvant treatment options and best follow‐up programs.
ISSN:2045-7634